The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
about
Giant osteoclast formation and long-term oral bisphosphonate therapyIbandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosisDrugs in development: bisphosphonates and metalloproteinase inhibitorsPeriprosthetic bone loss: diagnostic and therapeutic approachesBisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.Bisphosphonates and bone quality.Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitoninMechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosisThe impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.Effect of dietary calcium on spinal bone fusion in an ovariectomized rat modelTrabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.Comparative safety of bone remodeling agents with a focus on osteoporosis therapies.Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.Update on alendronate for osteoporosis: once-weekly dosing.A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.Intermittent dosing of alendronate.Osteopenia and osteoporosis in adult baboons (Papio hamadryas).Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogsThe potential role of bisphosphonates in prostate cancer.Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.Bone strength and its determinants.A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy.Possible antiosteoporotic mechanism of Cicer arietinum extract in ovariectomized ratsHormonal therapies and osteoporosis.A biomechanical perspective on bone quality.Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies.Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized RatsBiomechanical effects of simulated resorption cavities in cancellous bone across a wide range of bone volume fractions.Reproductive status and sex show strong effects on knee OA in a baboon model.Greater Skeletal Gains in Ovary Intact Rats at Maturity Are Achieved by Supplementing a Standardized Extract of Butea monosperma Stem Bark that Confers Better Bone Conserving Effect following Ovariectomy and Concurrent Treatment WithdrawalReceptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.The effect of vitamin D and bisphosphonate on fracture healing: An experimental studyAlendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.An in vitro assessment of fibroblast and osteoblast response to alendronate-modified titanium and the potential for decreasing fibrous encapsulation.Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatmentZoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cellsOsteoporosis in men: its pathophysiology and the role of teriparatide in its treatment.Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor
P2860
Q24626459-0CDE0C68-2D7F-4644-893B-65EC02750974Q24680238-1B3D701C-1E8F-4D79-838A-19E028DFEA57Q24795847-8C4C0708-0E58-411D-AB3E-2FF31FE23AEFQ27024847-1E6E5065-926F-472C-A94B-48B3B15D1621Q33666457-2BDB45A3-5ABE-44A6-8915-835DBB0B1E0EQ33683219-B352B5DE-F7E6-4D51-ADA7-416EBB5F27A2Q33902085-B972EE8F-DEF3-41DB-9ECF-00EF952137FDQ34009569-20E7F345-CCF9-458F-9278-334BF0822C3AQ34014578-7A027B02-D23F-404F-AC9C-C96BB7BD0F1FQ34028940-696E3975-D6FF-403F-A975-95E472495060Q34034279-8A857208-B09D-477C-BA59-340B9B099A1EQ34118018-C25D2B53-05D0-4488-979A-DFDEA78A4472Q34195727-67BB8861-96F9-419E-B8D1-EDB026EDC176Q34216887-40380DB8-070D-4AE9-9B72-F9DDD9F0B7BBQ34367479-5D3EEFB9-F15A-49E2-89D2-D66DE056A398Q34390360-3088E342-1DCC-4373-8358-79F09AA3052FQ34441705-05119872-5884-41F0-9628-3A342EDF1E33Q34449482-7BCA645A-A88C-40DC-A554-C872193DF426Q34457514-EE63DD39-37F5-42FE-B4EE-52AC64656542Q34758541-943AB2FD-D83F-4CC5-B287-C8FEF68E7720Q35081743-ACD39123-FC24-47DB-8874-B4BBC81C6D0CQ35083626-C7D43964-DF32-4D8D-B982-793FDF895CDCQ35121415-8C23BD4F-1FAB-4A68-87AB-497054FC3259Q35278061-D20B9D3A-88A3-4E85-9B4A-5FB7D31DF549Q35670191-776A5C57-DCD6-40E3-B1AE-4DF07E2A11B6Q35757566-4FB5549A-99F1-4483-8964-788549792A3EQ35809562-190B8437-9801-4219-9245-C4073E279EA0Q35901087-48B28252-5536-4FFB-BAD2-AEA30047F215Q36042959-2D7C71CF-5795-46A1-B59B-65F78B547D79Q36177145-8705C4C8-1C09-4DB7-B9C3-A8A78A9737FCQ36828468-4BBD3CEA-B73B-415D-822A-C24A8DD5009FQ36848642-4C5DF430-E5C2-4569-B02F-52600D9FC34AQ36860987-F9F602EE-E741-4E7E-B0A5-4F0E31808F81Q36871059-4E14244D-7B3E-45C9-8ED2-48C5A8E712DCQ36922156-096D9BAC-5865-42D0-9FE0-9442110CA79BQ37051881-DD5B7908-22F9-4EFD-8DC8-C7E72612DED3Q37056290-09063B53-5F9C-4EED-A50D-BBC09443948FQ37139859-BBE60F40-0E9D-4A5A-B5DD-33DD3675AA33Q37192997-7FA4B6DD-F04E-4BA5-B82F-FC54C78D813CQ37197357-D1A89B3D-4F2E-4F5A-A044-BA70CE1EE8BF
P2860
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@ast
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@en
type
label
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@ast
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@en
prefLabel
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@ast
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@en
P2093
P2860
P356
P1476
The effects of 2-year treatmen ...... riectomized nonhuman primates.
@en
P2093
Frankenfield D
Markatos A
P2860
P304
P356
10.1172/JCI116872
P407
P577
1993-12-01T00:00:00Z